Physician profile
Daniel S Lamar
NPI 1124094503
$5,818.57
in general payments reported to CMS, 2019-2025
23 companies · $538 in 2025
The $538 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $784 · 2020: $77.42 · 2021: $1,277 · 2022: $596 · 2023: $321 · 2024: $2,224 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,198 · Travel and Lodging: $886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,197.64 |
| Travel and Lodging | $885.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,314.61 | 2019-2025 | Mako, Insignia, Actishield |
| Arthrex, INC. | $1,280.91 | 2021-2024 | |
| Smith+Nephew, INC. | $654.73 | 2019-2024 | Healicoil, N/A, Goflo Pump |
| Coastal Medical Technologies LLC | $455.46 | 2024-2025 | |
| Horizon Therapeutics Plc | $321.22 | 2019-2022 | |
| Osprey Medical INC | $165.00 | 2021 | |
| Vericel Corporation | $99.87 | 2019-2023 | Maci |
| Heron Therapeutics, INC. | $84.93 | 2024 | Zynrelef |
| Orthofix Medical, INC. | $57.71 | 2019-2024 | Spinal-Stim |
| Mvp Orthopedics INC | $55.08 | 2021-2023 | |
| Ferring Pharmaceuticals INC. | $41.45 | 2020-2021 | |
| Bioventus LLC | $39.73 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $32.47 | 2019-2024 | Krystexxa |
| Avanos Medical | $31.59 | 2021 | |
| Sanofi-Aventis U.S. LLC | $30.92 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $28.32 | 2025 | |
| Convatec INC. | $23.54 | 2025 | |
| Portola Pharmaceuticals, LLC | $18.87 | 2019 | |
| Vertical Pharmaceuticals, LLC | $18.78 | 2019 | |
| Radius Health, INC. | $17.61 | 2022 | |
| Kci USA, INC. | $16.99 | 2021 | |
| Innovation Technologies INC | $15.61 | 2025 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $13.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lamar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.